↓ Skip to main content

Does Incorporating Cost-Effectiveness Analysis Into Prescribing Decisions Promote Drug Access Equity?

Overview of attention for article published in The AMA Journal of Ethic, August 2019
Altmetric Badge

Mentioned by

twitter
12 X users
facebook
1 Facebook page

Citations

dimensions_citation
4 Dimensions

Readers on

mendeley
26 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Does Incorporating Cost-Effectiveness Analysis Into Prescribing Decisions Promote Drug Access Equity?
Published in
The AMA Journal of Ethic, August 2019
DOI 10.1001/amajethics.2019.679
Pubmed ID
Authors

Michael J DiStefano, Jonathan S Levin

X Demographics

X Demographics

The data shown below were collected from the profiles of 12 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 26 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 26 100%

Demographic breakdown

Readers by professional status Count As %
Other 3 12%
Student > Ph. D. Student 3 12%
Student > Postgraduate 2 8%
Researcher 2 8%
Student > Bachelor 2 8%
Other 3 12%
Unknown 11 42%
Readers by discipline Count As %
Economics, Econometrics and Finance 4 15%
Medicine and Dentistry 3 12%
Business, Management and Accounting 2 8%
Agricultural and Biological Sciences 1 4%
Pharmacology, Toxicology and Pharmaceutical Science 1 4%
Other 2 8%
Unknown 13 50%